Ross Burdis

This study develops a biofabrication strategy combining vascular and hypertrophic cartilage microtissues with 3D-printed scaffolds to create scalable, prevascularized grafts for endochondral bone repair.

This paper develops an injectable hydrogel platform with poly(orthoester) microparticles for long-term, zero-order drug release, demonstrating in vitro and in vivo efficacy for up to 12 months.